Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs-Reference-Cited by-同舟云学术

Development of Potent and Selective Janus Kinase 2/3 Directing PG–PROTACs

Published:2022-02-21 Issue:3 Volume:13 Page:475-482
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Alcock Lisa J.¹,Chang Yunchao¹,Jarusiewicz Jamie A.²,Actis Marisa²,Nithianantham Stanley²,Mayasundari Anand²,Min Jaeki²^ORCID,Maxwell Dylan³,Hunt Jeremy³,Smart Brandon³,Yang Jun J.³,Nishiguchi Gisele²,Fischer Marcus²⁴,Mullighan Charles G.¹⁵,Rankovic Zoran²^ORCID

Affiliation:

1. Department of Pathology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States

2. Department of Chemical Biology and Therapeutics, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States

3. Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States

4. Department of Structural Biology, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States

5. Hematological Malignancies Program, St. Jude Comprehensive Cancer Center, St. Jude Children’s Research Hospital, Memphis, Tennessee 38105, United States

Funder

Snowdome Foundation

National Cancer Institute

American Lebanese Syrian Associated Charities

Leukemia and Lymphoma Society

National Institute of General Medical Sciences

St. Baldrick's Foundation

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link